Skip to main content
AAN.com
Articles
October 1, 1992

The epidemiology of myasthenia gravis in central and western Virginia

October 1992 issue
42 (10) 1888

Abstract

We conducted a study of the epidemiology of myasthenia gravis (MG) in four locations in central and western Virginia from 1970 through 1984. The population surveyed was 555,851 in 1984. A total of 73 new cases of MG occurred during the survey period, producing an overall average annual incidence rate of 9.1 per million. The point prevalence rate in 1980 was 13.4 per 100,000, and in 1984 it was 14.2. Approximately 15% of the population was black, and we found that incidence and prevalence rates for the black population were higher than the corresponding white population. When the population was subdivided into <50 and 50+ age groups, the incidence and prevalence were significantly higher in the older group. The rates we report here are higher than rates reported from any other locality. The reasons for the higher rates include optimal case identification, survey of a population with a higher incidence, and increasing aging of the population.

Get full access to this article

View all available purchase options and get full access to this article.

Information & Authors

Information

Published In

Neurology®
Volume 42Number 10October 1992
Pages: 1888
PubMed: 1407568

Publication History

Published online: October 1, 1992
Published in print: October 1992

Permissions

Request permissions for this article.

Authors

Affiliations & Disclosures

Lawrence H. Phillips, II, MD
Departments of Neurology (Drs. Phillips, Anderson, and Cox) and Neurosurgery (Dr. Torner), University of Virginia Health Sciences Center, Charlottesville, VA.
James C. Torner, PhD
Departments of Neurology (Drs. Phillips, Anderson, and Cox) and Neurosurgery (Dr. Torner), University of Virginia Health Sciences Center, Charlottesville, VA.
Michael S. Anderson, MD
Departments of Neurology (Drs. Phillips, Anderson, and Cox) and Neurosurgery (Dr. Torner), University of Virginia Health Sciences Center, Charlottesville, VA.
Gary M. Cox, MD
Departments of Neurology (Drs. Phillips, Anderson, and Cox) and Neurosurgery (Dr. Torner), University of Virginia Health Sciences Center, Charlottesville, VA.

Metrics & Citations

Metrics

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Myasthenic syndrome of Lambert-Eaton on the background of thyroid cancer (clinical case), Journal of Clinical Practice, (2023).https://doi.org/10.17816/clinpract119952
    Crossref
  2. Epidemiology of myasthenia gravis in the province of Ourense (Galicia, Spain), Neurología (English Edition), 38, 2, (75-81), (2023).https://doi.org/10.1016/j.nrleng.2020.06.013
    Crossref
  3. Epidemiología de la miastenia gravis en la provincia de Ourense (Galicia, noroeste de España), Neurología, 38, 2, (75-81), (2023).https://doi.org/10.1016/j.nrl.2020.06.011
    Crossref
  4. Incidence and prevalence of myasthenia gravis in the United States : A claims‐based analysis , Muscle & Nerve, (2023).https://doi.org/10.1002/mus.28006
    Crossref
  5. The Duke Myasthenia Gravis Clinic Registry: II . Analysis of outcomes , Muscle & Nerve, 67, 4, (291-296), (2023).https://doi.org/10.1002/mus.27794
    Crossref
  6. Myasthenia Gravis: Epidemiology, Pathophysiology and Clinical Manifestations, Journal of Clinical Medicine, 10, 11, (2235), (2021).https://doi.org/10.3390/jcm10112235
    Crossref
  7. The epidemiology of myasthenia gravis, Journal of Medicine and Life, 14, 1, (7-16), (2021).https://doi.org/10.25122/jml-2020-0145
    Crossref
  8. Global prevalence of myasthenia gravis and the effectiveness of common drugs in its treatment: a systematic review and meta-analysis, Journal of Translational Medicine, 19, 1, (2021).https://doi.org/10.1186/s12967-021-03185-7
    Crossref
  9. Pediatric Ptosis: A Review of Less Common Causes, International Ophthalmology Clinics, 62, 1, (177-202), (2021).https://doi.org/10.1097/IIO.0000000000000389
    Crossref
  10. Apheresetherapie in der KindernephrologieTherapeutic apheresis in pediatric nephrology, Der Nephrologe, 17, 3, (163-168), (2021).https://doi.org/10.1007/s11560-021-00552-9
    Crossref
  11. See more
Loading...

View Options

Get Access

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

Purchase this article to get full access to it.

Purchase Access, $39 for 24hr of access

View options

Full Text

View Full Text

Media

Figures

Other

Tables

Share

Share

Share article link

Share